March marks Colorectal Cancer Awareness Month! By 2030, colorectal cancer (CRC) is expected to become the leading cause of cancer-related deaths among individuals under 50 in the US. Even though it's recommended that those at average risk start screening for CRC at age 45, the rates of screening remain alarmingly low. At Geneoscopy, we are committed to bridging the screening gap and enhancing accessibility to screenings. Take action today: ? Understand the facts: Early detection is crucial. ? Evaluate your risk: Complete @FightCRC’s screening quiz to see if you might be at risk. ? Raise awareness: Share this information to help others recognize the importance of screening. Together, we can save lives. Discover more, assess your risk, and help spread the word. Visit: https://bit.ly/3rXmiqk #ColorectalCancerAwarenessMonth #Geneoscopy #CloseTheScreeningGap #FightCRC #EarlyDetectionSavesLives
Geneoscopy
生物技术研究
St. Louis,MO 6,858 位关注者
Cancer Prevention | Diagnostics | Precision Medicine
关于我们
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense? test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.
- 网站
-
https://geneoscopy.com
Geneoscopy的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- St. Louis,MO
- 类型
- 私人持股
- 创立
- 2015
- 领域
- Life Sciences、Noninvasive Diagnostic Screening、Colorectal Cancer Screening、GI Health、GI Disease Companion Diagnostics、seRNA、RNA Biomarkers、Precision Medicine Partnerships和IBD
地点
-
主要
2220 Welsch Industrial Ct
US,MO,St. Louis,63146
Geneoscopy员工
动态
-
We're #hiring a new DevOps Engineer III (Contract-to-Hire) in United States. Apply today or share this post with your network.
-
Geneoscopy转发了
Geneoscopy CEO and co-founder, Andrew Barnell, delivered impactful testimony today to?Congresswoman Ann Wagner (R-MO), Chair of the House Financial Services Subcommittee and representatives in Washington, DC,?regarding the vital role of startups in the US economy and the critical need to enhance their access to capital. #supportstartups #innovation #economicgrowth #STLMade #StLouis
-
-
Geneoscopy CEO and co-founder, Andrew Barnell, delivered impactful testimony today to?Congresswoman Ann Wagner (R-MO), Chair of the House Financial Services Subcommittee and representatives in Washington, DC,?regarding the vital role of startups in the US economy and the critical need to enhance their access to capital. #supportstartups #innovation #economicgrowth #STLMade #StLouis
-
-
Last week, Geneoscopy CEO Andrew Barnell met with Congressman Wesley Bell (D-MO) in Washington, D.C., to discuss our efforts to increase access to innovative colorectal cancer screening like ColoSense, promote health equity, and stimulate economic development in our hometown, St. Louis, and beyond. We are dedicated to making a difference! #CapitolHill #EconomicDevelopment #STLMade #StLouis #ScreeningSavesLives #MakingADifference
-
-
Colorectal cancer (CRC) is the second deadliest cancer in the U.S. However, millions of eligible Americans do not get screened due to a lack of access to or avoidance of invasive screening options like colonoscopies. The rates of CRC incidence among younger populations under 50 years old are also on the rise. ColoSense is Geneoscopy's FDA-approved at-home screening test for adults 45 and over who are at a typical risk for developing CRC. It uses an innovative, proprietary RNA-based platform to screen for CRC and advanced adenomas. Learn more at: https://bit.ly/40sqdNj
-
-
Today, we honor the leadership, vision, and dedication of the Presidents who have shaped our nation. Their commitment to progress reminds us of the importance of innovation, collaboration, and perseverance in building a better future. Wishing everyone a thoughtful and reflective President's Day. #innovation #leadership #PresidentsDay
-
-
This Valentine’s Day, in the same breath you say ‘I love you’…..don’t feel shy to finish that sentence with ‘get screened’. It could save a life. Visit https://bit.ly/4b1tbfr to learn more and send a little love: https://bit.ly/4gp743y #screeningsaveslives #colorectalcancer #ILoveYouGetScreened https://bit.ly/4aJvbsh
Cancer Screening | I Love You Get Screened.
https://www.youtube.com/
-
?? Happy International Women and Girls in Science Day! ?? Today, we celebrate the amazing contributions of women in science, especially at Geneoscopy. Your dedication and passion are shaping the future of healthcare. Thank you for inspiring us all! ???? #WomenInScience #GirlsInScience #Geneoscopy #STEM #InternationalWomenandGirlsinScienceDay #EmpowerHer #February11
-
This Black History Month, we join an important ally in advocacy, Colorectal Cancer Alliance, to raise awareness about cancer disparities affecting African Americans. More than one in three Black Americans is expected to face a cancer diagnosis in their lifetime, including disproportionately higher rates of colorectal cancer (CRC) and young-onset CRC. Regular screenings beginning at age 45 can prevent colorectal cancer, and early detection can make it easier to treat. Let's advocate for health equity and life-saving care. Learn more: https://bit.ly/4gnsOg1 #BlackHistoryMonth #ColorectalCancerAwareness
-